Wan-Ling Lai

Title: Wan-Ling Lai: Innovator in Stem Cell Therapy

Introduction

Wan-Ling Lai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the area of stem cell therapy. His innovative work focuses on the use of mesenchymal stem cells to treat immune-related diseases.

Latest Patents

Wan-Ling Lai holds a patent for the "Use of mesenchymal stem cells in treating immune-related diseases." This patent discloses a method for identifying a plurality of mesenchymal stem cells (MSCs) that are therapeutic for subjects suffering from immune-related diseases, such as arthritis. The MSCs are characterized by an immunosuppressive protein binding value (IPBv) greater than 170 toward indoleamine 2,3-dioxygenase (IDO) after exposure to 50-800 U/ml of IFN-γ. The patent also outlines the uses of these identified MSCs for the manufacture of a medicament and methods for treating immune-related diseases using the identified MSCs or medicament.

Career Highlights

Wan-Ling Lai is associated with Emo Biomedicine Corp., where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize treatments for immune-related conditions.

Collaborations

Some of his notable coworkers include Hung-Hsuan Chen and San-Ni Yu, who contribute to the innovative environment at Emo Biomedicine Corp.

Conclusion

Wan-Ling Lai's contributions to stem cell therapy highlight the potential of mesenchymal stem cells in treating immune-related diseases. His innovative approach and dedication to research continue to pave the way for advancements in medical treatments.